EDONUM - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 187,755 | 119,740 | 113,544 | 251,330 | 465,874 | 2,115,588 | 1,521,578 | 1,393,595 |
| Profit before tax | - | - | - | - | - | 286,285 | 176,484 | 3,018 |
| Net profit | 47,551 | 1,061 | 703 | 16,766 | 3,308 | 240,799 | 148,864 | 2,242 |
| Equity | 2,896 | 80,605 | 81,308 | 98,074 | 101,382 | 318,653 | 467,517 | 446,229 |
| Liabilities | 95,915 | 95,756 | 143,241 | 98,138 | 358,055 | 159,275 | 208,905 | 128,303 |
| Non-current assets | 44,881 | 27,016 | 59,113 | 54,484 | 52,359 | 31,615 | 223,531 | 259,755 |
| Current assets | 130,577 | 149,345 | 165,436 | 141,728 | 407,078 | 445,930 | 448,569 | 310,854 |
| Total assets | 175,458 | 176,361 | 224,549 | 196,212 | 459,437 | 477,545 | 672,100 | 570,609 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 403,852 | 289,766 | 267,131 |
| Social insurance contributions | - | - | - | - | - | 1,395 | 9,479 | 19,172 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +27.6% | -36.2% | -5.2% | +121.4% | +85.4% | +354.1% | -28.1% | -8.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 27.1% | 0.6% | 0.3% | 8.5% | 0.7% | 50.4% | 22.1% | 0.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 1642.0% | 1.3% | 0.9% | 17.1% | 3.3% | 75.6% | 31.8% | 0.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 25.3% | 0.9% | 0.6% | 6.7% | 0.7% | 11.4% | 9.8% | 0.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | 13.5% | 11.6% | 0.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 33.1 | 1.2 | 1.8 | 1.0 | 3.5 | 0.5 | 0.4 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 187,755 | 119,740 | 71,714 | 215,420 | 266,214 | 818,948 | 424,630 | 348,399 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
EDONUM - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-19 | 2026-07-23 | 1539.83 |
| 2026-07-16 | 2026-07-17 | 1539.83 |
| 2026-03-29 | 2026-04-08 | 0.10 |
| 2026-03-17 | 2026-03-27 | 0.10 |
| 2026-02-18 | 2026-03-09 | 0.12 |
| 2026-01-16 | 2026-02-09 | 0.14 |
| 2026-01-01 | 2026-01-08 | 0.15 |
| 2025-12-16 | 2025-12-30 | 0.15 |
| 2025-11-18 | 2025-12-11 | 0.19 |
| 2025-10-23 | 2025-11-09 | 0.21 |
| 2025-07-17 | 2025-08-10 | 33.95 |
| 2025-02-18 | 2025-03-13 | 6.08 |
| 2025-02-10 | 2025-02-10 | 6.09 |
| 2025-01-22 | 2025-02-06 | 6.09 |
| 2024-10-16 | 2024-10-28 | 1513.04 |
| 2024-02-19 | 2024-03-05 | 0.36 |
| 2024-01-23 | 2024-02-04 | 0.36 |
| 2024-01-16 | 2024-01-22 | 0.30 |
| 2023-12-18 | 2024-01-04 | 0.30 |
| 2023-11-28 | 2023-12-05 | 0.30 |
| 2023-11-16 | 2023-11-26 | 0.30 |
| 2023-10-27 | 2023-11-08 | 0.30 |
| 2023-10-25 | 2023-10-25 | 0.30 |
| 2023-07-18 | 2023-07-23 | 199.90 |
| 2023-05-16 | 2023-06-11 | 3.09 |
| 2023-05-02 | 2023-05-07 | 3.09 |
| 2023-04-27 | 2023-04-28 | 3.09 |
| 2023-04-25 | 2023-04-25 | 3.09 |
| 2023-03-16 | 2023-04-02 | 541.70 |
| 2022-02-17 | 2022-03-14 | 0.14 |
| 2022-01-28 | 2022-02-06 | 0.14 |
EDONUM - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company EDONUM is: 4 €
| From | To | Overdue, € |
|---|---|---|
| 2026-09-01 | 2026-09-02 | 3.71 |
| 2026-07-31 | 2026-08-26 | 5.43 |
| 2026-07-02 | 2026-07-07 | 28.61 |
| 2026-06-30 | 2026-07-01 | 8705.07 |
| 2026-06-28 | 2026-06-29 | 8709.11 |
| 2026-06-04 | 2026-06-04 | 1634.11 |
| 2026-06-01 | 2026-06-03 | 1632.79 |
| 2026-05-28 | 2026-05-31 | 1626.31 |
| 2025-12-18 | 2025-12-18 | 7342.28 |
| 2025-09-19 | 2025-09-19 | 7358.03 |
| 2025-08-12 | 2025-08-12 | 34.84 |
| 2025-08-08 | 2025-08-11 | 76.56 |
| 2025-08-01 | 2025-08-07 | 34.84 |
| 2025-07-28 | 2025-07-29 | 32271.0 |
| 2025-06-26 | 2025-07-20 | 14.83 |
| 2025-06-22 | 2025-06-24 | 16439.37 |
| 2025-06-19 | 2025-06-21 | 16421.65 |
| 2025-05-13 | 2025-05-13 | 678.49 |
| 2024-12-19 | 2024-12-19 | 11237.02 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
EDONUM, UAB is a private limited liability company (code 302300106) operating in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €1.39 million, down 8.4% year on year and 34.1% below the 2023 level of €2.12 million. Profitability weakened sharply: net profit fell to €2.2K in 2025 from €148.9K in 2024 and €240.8K in 2023, leaving a profit margin of 0.2% in the latest year. The 2024 result had already been lower than 2023, but the 2025 decline was much more pronounced. At year-end 2025, total assets stood at €570.6K, equity at €446.2K and liabilities at €128.3K, indicating a strong equity position with a debt-to-equity ratio of 0.29. The equity ratio was 78.2%, while asset turnover remained solid at 2.44x. Return on equity was 0.5% and return on assets 0.4%, both reflecting the weak profit base in 2025. Revenue per employee was €348.4K, while profit per employee fell to €560.